OPKO Health Total Long Term Liabilities 2010-2024 | OPK

OPKO Health total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
OPKO Health Annual Total Long Term Liabilities
(Millions of US $)
2023 $422
2022 $392
2021 $385
2020 $426
2019 $445
2018 $371
2017 $434
2016 $412
2015 $567
2014 $349
2013 $427
2012 $59
2011 $50
2010 $27
2009 $43
OPKO Health Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $641
2024-06-30 $365
2024-03-31 $517
2023-12-31 $422
2023-09-30 $412
2023-06-30 $397
2023-03-31 $395
2022-12-31 $392
2022-09-30 $328
2022-06-30 $435
2022-03-31 $383
2021-12-31 $385
2021-09-30 $369
2021-06-30 $375
2021-03-31 $419
2020-12-31 $426
2020-09-30 $412
2020-06-30 $456
2020-03-31 $439
2019-12-31 $445
2019-09-30 $457
2019-06-30 $464
2019-03-31 $417
2018-12-31 $371
2018-09-30 $375
2018-06-30 $414
2018-03-31 $438
2017-12-31 $434
2017-09-30 $374
2017-06-30 $379
2017-03-31 $388
2016-12-31 $412
2016-09-30 $440
2016-06-30 $477
2016-03-31 $528
2015-12-31 $567
2015-09-30 $689
2015-06-30 $518
2015-03-31 $517
2014-12-31 $349
2014-09-30 $331
2014-06-30 $335
2014-03-31 $440
2013-12-31 $427
2013-09-30 $444
2013-06-30 $269
2013-03-31 $276
2012-12-31 $59
2012-09-30 $57
2012-06-30 $47
2012-03-31 $47
2011-12-31 $50
2011-09-30 $28
2011-06-30 $28
2011-03-31 $28
2010-12-31 $27
2010-09-30 $27
2010-06-30 $1
2010-03-31 $1
2009-12-31 $43
2009-09-30 $15
2009-06-30 $14
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.065B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.408B 24.08
Intuitive Surgical (ISRG) United States $196.120B 102.54
Alcon (ALC) Switzerland $42.207B 28.24
Edwards Lifesciences (EW) United States $41.510B 26.36
IQVIA Holdings (IQV) United States $35.864B 19.76
IDEXX Laboratories (IDXX) United States $34.273B 40.36
DexCom (DXCM) United States $29.084B 43.80
Waters (WAT) United States $21.880B 32.35
STERIS (STE) Ireland $21.298B 24.52
SONOVA HOLDING (SONVY) Switzerland $20.458B 0.00
Hologic (HOLX) United States $18.284B 19.29
Fresenius Medical Care AG KGaA (FMS) Germany $12.898B 13.24
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Globus Medical (GMED) United States $11.562B 29.28
Penumbra (PEN) United States $9.230B 90.41
Masimo (MASI) United States $9.055B 43.81
Teleflex (TFX) United States $8.854B 14.12
Glaukos (GKOS) United States $7.765B 0.00
PROCEPT BioRobotics (PRCT) United States $4.929B 0.00
Integer Holdings (ITGR) United States $4.558B 25.83
Veracyte (VCYT) United States $3.018B 90.56
Inari Medical (NARI) United States $2.913B 0.00
LivaNova (LIVN) United Kingdom $2.807B 16.21
TransMedics (TMDX) United States $2.663B 84.40
Nihon Kohden (NHNKY) Japan $2.428B 18.44
Elekta AB (EKTAY) Sweden $2.125B 17.31
Tandem Diabetes Care (TNDM) United States $2.019B 0.00
RxSight (RXST) United States $1.816B 0.00
Integra LifeSciences Holdings (IART) United States $1.775B 9.27
Alphatec Holdings (ATEC) United States $1.448B 0.00
Artivion (AORT) United States $1.175B 77.86
Pulse Biosciences (PLSE) United States $0.992B 0.00
Paragon 28 (FNA) United States $0.873B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.828B 14.08
ORTHOFIX MEDICAL INC (OFIX) United States $0.714B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.641B 0.00
AxoGen (AXGN) United States $0.577B 0.00
Mesa Laboratories (MLAB) United States $0.548B 12.91
SiBone (SIBN) United States $0.515B 0.00
Treace Medical Concepts (TMCI) United States $0.495B 0.00
Pacific Biosciences Of California (PACB) United States $0.485B 0.00
Semler Scientific (SMLR) United States $0.483B 32.40
Tactile Systems Technology (TCMD) United States $0.383B 20.70
CVRx (CVRX) United States $0.358B 0.00
Delcath Systems (DCTH) United States $0.315B 0.00
ClearPoint Neuro (CLPT) United States $0.306B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
NeuroPace (NPCE) United States $0.269B 0.00
Inogen (INGN) United States $0.219B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.190B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Nevro (NVRO) United States $0.163B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.150B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.67
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.087B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Covalon Technologies (CVALF) Canada $0.077B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
Vicarious Surgical (RBOT) United States $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
Neuronetics (STIM) United States $0.025B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00